Does Endothelin Play a Role in the Pathogenesis of Early Diabetic Nephropathy?

Q: What is the clinical evidence from this study?

Population: Diabetic Nephropathy. Intervention: Endothelin.

Hing‐Chung Lam; Jenn‐Kuen Lee; Hung‐Ting Chiang; Shu-Jing Koh; Tian-Mu Han; Chih-Chen Lu; Chwen-Yi Yang; Lih-Jyh Hao

doi:10.1097/00005344-199526003-00141

January 1, 1995Journal of Cardiovascular Pharmacology

Does Endothelin Play a Role in the Pathogenesis of Early Diabetic Nephropathy?

View at Publisher

Ask AI

Bookmark

Share

Key Points

Assess whether endothelin contributes to the onset and progression of early diabetic nephropathy.
Review and evaluation of cardiovascular pharmacology frameworks covering drug mechanisms and metabolic actions.
Specific empirical results and effect sizes are not reported in the source text.
Identifies the development and evaluation of targeted pharmacological agents as central to managing cardiovascular and related disorders.

PICO

P

Population

Diabetic Nephropathy

E

Exposure / Comparator

Endothelin

Ask about this paper

Answers are grounded in this paper and cite their sources.

Implication

Examines the involvement of endothelin in early diabetic kidney damage, highlighting potential targets for cardiovascular pharmacology.

Abstract

No abstract yet. The journal hasn't published one we can show.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Lam et al. (1995) studied Diabetic Nephropathy. Endothelin was evaluated.

synapsesocial.com/papers/6a933c761752b8b896205d0e https://doi.org/10.1097/00005344-199526003-00141

View at Publisher

Ask AI

Bookmark

Share

Does Endothelin Play a Role in the Pathogenesis of Early Diabetic Nephropathy?

Key Points

PICO

Ask about this paper

Implication

Abstract

Discussion

Cite This Study

Does Endothelin Play a Role in the Pathogenesis of Early Diabetic Nephropathy?

Key Points

PICO

Ask about this paper

Implication

Abstract

Discussion

Cite This Study

Keep reading

Keep reading